{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:08:50Z","timestamp":1788509330700,"version":"build-2803163510"},"reference-count":63,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"RFBR","doi-asserted-by":"publisher","award":["20-04-60038"],"award-info":[{"award-number":["20-04-60038"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>In the present work we studied the antiviral activity of the home library of monoterpenoid derivatives using the pseudoviral systems of our development, which have glycoproteins of the SARS-CoV-2 virus strains Wuhan and Delta on their surface. We found that borneol derivatives with a tertiary nitrogen atom can exhibit activity at the early stages of viral replication. In order to search for potential binding sites of ligands with glycoprotein, we carried out additional biological tests to study the inhibition of the re-receptor-binding domain of protein S. For the compounds that showed activity on the pseudoviral system, a study using three strains of the infectious SARS-CoV-2 virus was carried out. As a result, two leader compounds were found that showed activity on the Wuhan, Delta, and Omicron strains. Based on the biological results, we searched for the potential binding site of the leader compounds using molecular dynamics and molecular docking methods. We suggested that the compounds can bind in conserved regions of the central helices and\/or heptad repeats of glycoprotein S of SARS-CoV-2 viruses.<\/jats:p>","DOI":"10.3390\/v14061295","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T01:39:54Z","timestamp":1655257194000},"page":"1295","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2333-4893","authenticated-orcid":false,"given":"Olga I.","family":"Yarovaya","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, Lavrentiev ave., 9, 630090 Novosibirsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8023-4453","authenticated-orcid":false,"given":"Dmitriy N.","family":"Shcherbakov","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-0470","authenticated-orcid":false,"given":"Sophia S.","family":"Borisevich","sequence":"additional","affiliation":[{"name":"Laboratory of Chemical Physics Ufa Institute of Chemistry, Ufa Federal Research Center, RAS, Octyabrya pr., 71, 450054 Ufa, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya S.","family":"Sokolova","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, Lavrentiev ave., 9, 630090 Novosibirsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0385-922X","authenticated-orcid":false,"given":"Maxim A.","family":"Gureev","sequence":"additional","affiliation":[{"name":"Research Center \u201cDigital Biodesign and Personalized Healthcare\u201d, I.M. Sechenov First Moscow State Medical University, Trubetskaya str., 8\/2, 119991 Moscow, Russia"},{"name":"Department of Computational Biology, Sirius University of Science and Technology, Olympic Ave., 1, 354340 Sochi, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8987-4254","authenticated-orcid":false,"given":"Edward M.","family":"Khamitov","sequence":"additional","affiliation":[{"name":"Laboratory of Chemical Physics Ufa Institute of Chemistry, Ufa Federal Research Center, RAS, Octyabrya pr., 71, 450054 Ufa, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezda B.","family":"Rudometova","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya V.","family":"Zybkina","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina D.","family":"Mordvinova","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, Lavrentiev ave., 9, 630090 Novosibirsk, Russia"},{"name":"State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Zaykovskaya","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3338-8529","authenticated-orcid":false,"given":"Artem D.","family":"Rogachev","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, Lavrentiev ave., 9, 630090 Novosibirsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg V.","family":"Pyankov","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat A.","family":"Maksyutov","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariman F.","family":"Salakhutdinov","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry SB RAS, Lavrentiev ave., 9, 630090 Novosibirsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_2","unstructured":"WHO (2022). COVID-19 Weekly Epidemiological Update, World Health Organisation."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41418-020-00720-9","article-title":"COVID-19 vaccines: Where we stand and challenges ahead","volume":"28","author":"Forni","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1070\/RCR4961","article-title":"Molecular basis of COVID-19 pathogenesis","volume":"89","author":"Novikov","year":"2020","journal-title":"Russ. Chem. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fmed.2020.581521","article-title":"Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks","volume":"7","author":"Mann","year":"2020","journal-title":"Front. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Khan, M., Adil, S.F., Alkhathlan, H.Z., Tahir, M.N., Saif, S., Khan, M., and Khan, S.T. (2020). COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules, 26.","DOI":"10.3390\/molecules26010039"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e149187","DOI":"10.1172\/jci.insight.149187","article-title":"SARS-CoV-2 vaccines: A triumph of science and collaboration","volume":"6","author":"Golob","year":"2021","journal-title":"JCI Insight"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40249-021-00915-3","article-title":"Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: A systematic review and meta-analysis","volume":"10","author":"Liu","year":"2021","journal-title":"Infect. Dis. Poverty"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Rolland, M., and Gilbert, P.B. (2021). Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009406"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/jmv.27513","article-title":"The variants of SARS-CoV-2 and the challenges of vaccines","volume":"94","author":"Han","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ane.13550","article-title":"Neurological side effects of SARS-CoV-2 vaccinations","volume":"145","author":"Finsterer","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-022-00884-5","article-title":"Structural biology of SARS-CoV-2: Open the door for novel therapies","volume":"7","author":"Yan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1021\/acscentsci.1c00910","article-title":"Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay","volume":"8","author":"Cao","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e00044-21","DOI":"10.1128\/JVI.00044-21","article-title":"Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays","volume":"95","author":"Yu","year":"2021","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.7150\/ijbs.59184","article-title":"Construction and applications of SARS-CoV-2 pseudoviruses: A mini review","volume":"17","author":"Chen","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rawson, J.M.O., Duchon, A., Nikolaitchik, O.A., Pathak, V.K., and Hu, W.S. (2021). Development of a cell-based luciferase complementation assay for identification of sars-cov-2 3clpro inhibitors. Viruses, 13.","DOI":"10.3390\/v13020173"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s13238-020-00803-w","article-title":"Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD\/ACE2 interaction","volume":"12","author":"Fu","year":"2021","journal-title":"Protein Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1007\/s10096-021-04284-5","article-title":"Performance of a SARS CoV-2 antibody ELISA based on simultaneous measurement of antibodies against the viral nucleoprotein and receptor-binding domain","volume":"40","author":"Reiners","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"113966","DOI":"10.1016\/j.ejmech.2021.113966","article-title":"Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV","volume":"227","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e20201181","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses","volume":"217","author":"Schmidt","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejmech.2015.10.010","article-title":"Discovery of a new class of antiviral compounds: Camphor imine derivatives","volume":"105","author":"Sokolova","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1016\/j.bmc.2013.08.014","article-title":"New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity","volume":"21","author":"Sokolova","year":"2013","journal-title":"Bioorganic Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1039\/C6MD00657D","article-title":"Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus","volume":"8","author":"Sokolova","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"112726","DOI":"10.1016\/j.ejmech.2020.112726","article-title":"Monoterpenoid-based inhibitors of filoviruses targeting the glycoprotein-mediated entry process","volume":"207","author":"Sokolova","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e1800153","DOI":"10.1002\/cbdv.201800153","article-title":"Discovery of a New Class of Inhibitors of Vaccinia Virus Based on (\u2212)-Borneol from Abies sibirica and (+)-Camphor","volume":"15","author":"Sokolova","year":"2018","journal-title":"Chem. Biodivers."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2022586118","DOI":"10.1073\/pnas.2022586118","article-title":"The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV","volume":"118","author":"Benton","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41467-022-28528-w","article-title":"Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_29","unstructured":"Ni, D., Lau, K., Turelli, P., Raclot, C., Beckert, B., Nazarov, S., Pojer, F., Myasnikov, A., Stahlberg, H., and Trono, D. (2021). Structural analysis of the Spike of the Omicron SARS-COV-2 variant by cryo-EM and implications for immune evasion. bioRxiv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1063\/1.456153","article-title":"Gaussian basis sets for use in correlated molecular calculations. I. The atoms boron through neon and hydrogen","volume":"90","author":"Dunning","year":"1989","journal-title":"J. Chem. Phys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences","volume":"113","author":"Bochevarov","year":"2013","journal-title":"Int. J. Quantum Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1021\/acs.jctc.6b00805","article-title":"Multiconformation, Density Functional Theory-Based p K a Prediction in Application to Large, Flexible Organic Molecules with Diverse Functional Groups","volume":"12","author":"Bochevarov","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105998","DOI":"10.1016\/j.ijantimicag.2020.105998","article-title":"Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein","volume":"56","author":"Vankadari","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Borisevich, S.S., Khamitov, E.M., Gureev, M.A., Yarovaya, O.I., Rudometova, N.B., Zybkina, A.V., Mordvinova, E.D., Shcherbakov, D.N., Maksyutov, R.A., and Salakhutdinov, N.F. (2022). Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights. Viruses, 14.","DOI":"10.3390\/v14010119"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bowers, K.J., Sacerdoti, F.D., Salmon, J.K., Shan, Y., Shaw, D.E., Chow, E., Xu, H., Dror, R.O., Eastwood, M.P., and Gregersen, B.A. (2006, January 11\u201317). Molecular dynamics\u2014Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing-SC \u201906, Tampa, FL, USA.","DOI":"10.1145\/1188455.1188544"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Suenaga, A., Okimoto, N., Hirano, Y., and Fukui, K. (2012). An Efficient Computational Method for Calculating Ligand Binding Affinities. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042846"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Repasky, M.P., Shelley, M., and Friesner, R.A. (2007). Flexible Ligand Docking with Glide. Current Protocols in Bioinformatics, John Wiley & Sons, Inc.","DOI":"10.1002\/0471250953.bi0812s18"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","article-title":"On the Role of the Crystal Environment in Determining Protein Side-chain Conformations","volume":"320","author":"Jacobson","year":"2002","journal-title":"J. Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.antiviral.2015.06.004","article-title":"Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo","volume":"120","author":"Zarubaev","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2018.08.011","article-title":"Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity","volume":"524","author":"Zarubaev","year":"2018","journal-title":"Virology"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Borisevich, S.S., Gureev, M.A., Yarovaya, O.I., Zarubaev, V.V., Kostin, G.A., Porozov, Y.B., and Salakhutdinov, N.F. (2021). Can molecular dynamics explain decreased pathogenicity in mutant camphecene-resistant influenza virus?. J. Biomol. Struct. Dyn., 1\u201312.","DOI":"10.1080\/07391102.2020.1871414"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/fcp.12750","article-title":"Optimization of application schedule of camphecene, a novel anti-influenza compound, based on its pharmacokinetic characteristics","volume":"36","author":"Zarubaev","year":"2022","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejmech.2016.10.035","article-title":"Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N","volume":"127","author":"Sokolova","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2100038","DOI":"10.1002\/ardp.202100038","article-title":"(+)-Camphor and (\u2212)-borneol derivatives as potential anti-orthopoxvirus agents","volume":"354","author":"Sokolova","year":"2021","journal-title":"Arch. Pharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1039\/C7MD00424A","article-title":"N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry","volume":"8","author":"Kononova","year":"2017","journal-title":"Med. Chem. Comm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"103703","DOI":"10.1016\/j.ebiom.2021.103703","article-title":"Alpha variant SARS-CoV-2 infection: How it all starts","volume":"74","author":"Domingo","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","article-title":"Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: A cohort study","volume":"22","author":"Twohig","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/jmv.27626","article-title":"Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant","volume":"94","author":"Sharma","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/mra.01161-21","article-title":"Identification of the First SARS-CoV-2 Lineage B.1.1.529 Virus Detected in Europe","volume":"11","author":"Vanmechelen","year":"2022","journal-title":"Microbiol. Resour. Announc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00705-021-05102-1","article-title":"Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus","volume":"166","author":"Sokolova","year":"2021","journal-title":"Arch. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17736","DOI":"10.1073\/pnas.0807142105","article-title":"Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion","volume":"105","author":"Russell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.virol.2015.03.043","article-title":"Viral membrane fusion","volume":"479\u2013480","author":"Harrison","year":"2015","journal-title":"Virology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1021\/acscentsci.0c01056","article-title":"Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein","volume":"6","author":"Casalino","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Chen, Z., Cui, Q., Caffrey, M., Rong, L., and Du, R. (2021). Small molecule inhibitors of influenza virus entry. Pharmaceuticals, 14.","DOI":"10.3390\/ph14060587"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41421-020-0169-8","article-title":"The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro","volume":"6","author":"Wang","year":"2020","journal-title":"Cell Discov."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.4876","article-title":"Determining available strategies for prevention and therapy: Exploring COVID-19 from the perspective of ACE2 (Review)","volume":"47","author":"Cai","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1128\/JVI.02278-13","article-title":"Structural Stability of Influenza A(H1N1)pdm09 Virus Hemagglutinins","volume":"88","author":"Yang","year":"2014","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1295\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:31:03Z","timestamp":1760139063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["v14061295"],"URL":"https:\/\/doi.org\/10.3390\/v14061295","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]}}}